FindTrial
Sign In

Niagen

DIETARY_SUPPLEMENT6 trials

Sponsors

University of Maryland, Baltimore, Steven E Arnold, MD, National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Maastricht University Medical Center

Conditions

AgingAtherosclerotic Cardiovascular DiseaseCardiometabolic DiseasesCognition Disorders in Old AgeCognitive DeclineCognitive SymptomCovid19Diabetic Neuropathy Peripheral

Phase 1

Nicotinamide Riboside for Diabetic Neuropathy
TerminatedNCT03685253
University of Maryland, BaltimoreDiabetic Neuropathy Peripheral
Start: 2019-01-24End: 2022-05-01Updated: 2026-01-06

Phase 4

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19
CompletedNCT04809974
Massachusetts General HospitalCognitive Symptom, Covid19, Sequelae of; Infection
Start: 2021-08-28End: 2024-02-23Updated: 2025-08-05

Unknown Phase

Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment
CompletedNCT04078178
Steven E Arnold, MDCognition Disorders in Old Age, Cognitive Decline, Mild Cognitive Impairment
Start: 2020-10-30End: 2022-09-30Updated: 2024-11-29
Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
CompletedNCT04271735
National Heart, Lung, and Blood Institute (NHLBI)Atherosclerotic Cardiovascular Disease, Cardiometabolic Diseases, Dyslipidemia +2
Start: 2020-08-26End: 2022-12-19Updated: 2026-09-09
NR Supplementation and Exercise
CompletedNCT04907110
Maastricht University Medical CenterAging, Overweight and Obesity, Type 2 Diabetes
Start: 2021-08-10End: 2022-12-07Updated: 2023-02-10
Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)
Active, not recruitingNCT06005350
Charite University, Berlin, GermanyNAD
Start: 2023-11-01End: 2024-12-31Target: 54Updated: 2024-06-13

Related Papers

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial.
2025-11-12